ArticleThe New England journal of medicine2001
Paroxetine for the prevention of depression induced by interferon alfa.
Article in The New England journal of medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00227149 (Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C Infection and a Former), which is not on this map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C Infection and a Former (Peg)Interferon Alfa-2b-Based Therapy
Who cites it
11 citing papers in PubMed, 50 citations in OpenAlex.
- Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C.World journal of gastroenterology · 2005Trial
- The role of neuroinflammation and neurovascular dysfunction in major depressive disorder.Journal of inflammation research · 2018Review
- Pharmacological management of depression in patients with cancer: practical considerations.Drugs · 2013Review
- What the infectious disease physician needs to know about pegylated interferon and ribavirin.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013Review
- Major depression during interferon-alpha treatment: vulnerability and prevention.Dialogues in clinical neuroscience · 2009Article
- Depression following pegylated interferon-alpha: characteristics and vulnerability.Journal of psychosomatic research · 2007Article
- Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review.International journal of methods in psychiatric research · 2007Review
- Hepatitis C treatment of patients with bipolar disorder: a case series.Primary care companion to the Journal of clinical psychiatry · 2006Article
- Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.Journal of urban health : bulletin of the New York Academy of Medicine · 2004Article
- [Hepatitis (Hep-Net) competence network].Der Internist · 2004Article
- Neuropsychiatric side effects of interferon-alfa therapy.Pharmacy world & science : PWS · 2003Review
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
11484704W52880915What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.